Lung Fusion (FFPE, Cytology Smear)

This test is intended for the detection of clinically relevant ALK, RET and ROS1 fusion genes in lung cancer samples with at least 10 percent tumor cells and adequate RNA. The assay is designed for detection of specific isoforms present in ~95-98% of ALK, RET and ROS1 fusion-containing specimens, with additional ability to detect the presence of novel isoforms.  When novel isoforms are suspected, additional follow-up testing will be recommended.

For more details and ordering, please click here.